2019
DOI: 10.1007/s00432-019-02938-8
|View full text |Cite
|
Sign up to set email alerts
|

HALFMOON TomoTherapy (Helical ALtered Fractionation for iMplant partial OmissiON): implant-sparing post-mastectomy radiotherapy reshaping the clinical target volume in the reconstructed breast

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
11
1

Year Published

2021
2021
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(13 citation statements)
references
References 32 publications
1
11
1
Order By: Relevance
“…We also note that the patients in this study were scanned using deep-inspiration breath-hold, which is not feasible with all helicoidal tomotherapy techniques. Our results with helicoidal tomotherapy are similar to those reported in the HALF-MOON helicoidal tomotherapy publication by Leonardi et al [19], in which the HALFMOON helicoidal tomotherapy plans are shaped around the CTV but had more dose to the heart (MHD 4.5 Gy compared with conventional FiF 2.5 Gy), lungs and contralateral breast, compared with three-dimensional conformal radiation therapy planning.…”
Section: Discussionsupporting
confidence: 88%
“…We also note that the patients in this study were scanned using deep-inspiration breath-hold, which is not feasible with all helicoidal tomotherapy techniques. Our results with helicoidal tomotherapy are similar to those reported in the HALF-MOON helicoidal tomotherapy publication by Leonardi et al [19], in which the HALFMOON helicoidal tomotherapy plans are shaped around the CTV but had more dose to the heart (MHD 4.5 Gy compared with conventional FiF 2.5 Gy), lungs and contralateral breast, compared with three-dimensional conformal radiation therapy planning.…”
Section: Discussionsupporting
confidence: 88%
“…The results were evaluated within the 95% confidence interval and the significance was evaluated under p < 0.05. Accurate sample size was calculated by a method developed by Cohen (d-value) based on the study by Leonardi et al G-power program (version 3.1) was used to calculate the sample size of 16 with 95% confidence interval (1 − α), 90% power (1 − β) with an estimated mean difference of 4.5 between two groups [ 21 ].…”
Section: Methodsmentioning
confidence: 99%
“…This is also a challenge for radiation oncologists and medical physicists. Prospective trials are necessary to ensure that these new techniques do not compromise oncologic outcomes [13][14][15][16].…”
Section: Effect Of the Calculation Grid On The Results Of The Dose Distributionmentioning
confidence: 99%